|
|
|
1125: Use of Color Intensity Projections (CIP) for 4D Respiration-Gated Radiotherapy (RGRT)
|
Slotman, Ben |
|
1126: Intensity Synchronized Radiotherapy (ISRT) with Conventional Fractionation Schedule using Fiducial Markers and Real-Time Tumor-Tracking Radiotherapy (RTRT) System for Locally Advanced Lung Cancer
|
Shirato, Hiroki |
|
1127: Quantification of Mediastinal Lymph Node Movement Using 4D CT Scan: Implications for Radiation Treatment Planning
|
Sher, David |
|
1128: Long-Term Follow-up of 153 Candidates for Definitive Radiation or Chemoradiation Therapy with Non-Small Cell Lung Cancer who were Staged by PET: Implications for Design of Future Randomized Trials
|
MacManus, Michael |
|
1129: Using FDG-PET and V/Q SPECT to Assess Changes in Tumor Activity and Pulmonary Function during Radiotherapy ofNon-Small Cell Lung Cancer
|
Kong, Feng-Ming |
|
1130: Could Functional MRI Improve Radiation Therapy Planning in Non-Small Cell Lung Cancer?
|
Arnold, Johannes |
|
1131: FDG-PET and Stereotactic Body Radiotherapy (SBRT) for Stage I Non-small Cell Lung Cancer
|
Hoopes, David |
|
1132: Results of a Phase I Dose Escalation Study Using Single Fraction Stereotactic Radiosurgery (SFSR) For Lung Tumors
|
Le, Quynh-Thu |
|
1133: Exclusion of Elective Nodal Irradiation does not Decrease Local Regional Control of Non-Small Cell Lung Cancer
|
Sulman, Erik |
|
1134: Comparison of Outcomes for Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer Treated with Two-Dimensional versus Three-Dimensional Radiotherapy
|
Fang, L. Christine |
|
1135: A Comparison of Two-Dimensional and Conformal Radiotherapy for Post-Operative Treatment of Non-Small Cell Lung Cancer (NSCLC)
|
Gupta, Vishal |
|
1136: Improved Prediction of Radiation Pneumonitis using Multiple Additive Regression Trees
|
Das, Shiva |
|
1137: Radiation Pneumonitis in Lung Cancer Patients - The Neglected Patient-Related Variables
|
Bezjak, Andrea |
|
1138: Analysis of Clinical and Dosimetric Factors Influencing Acute Esophagitis in Patients with Non-Small Cell Lung Cancer Treated with Concurrent Chemotherapy and Three Dimensional Conformal Radiotherapy
|
Wei, Xiong |
|
1139: Back To B.E.D... Predictors of Outcome in RTOG Non-Operative Non-Small Cell Lung Cancer (NSCLC) Trials
|
Movsas, Benjamin |
|
1140: Clinical, Dosimetric, and Location-Related Factors to Predict Local Control in Non-Small Cell Lung Cancer
|
Hope, Andrew |
|
2267: Endobronchial Brachytherapy (EBBT) as a Curative Treatment: Results in 106 Patients with a Limited Endobronchial Disease
|
Hennequin, Christophe |
|
2268: Investigating the Effects of Respiratory Gated IMRT Treatment Delivery on Survival
|
Chang, Michael |
|
2269: Metabolic Tumor Burden Predicts for Disease Progression in Lung Cancer
|
Lee, Percy |
|
2270: Prospective Assessment of Models to Predict Radiation Pneumonitis Based on Dosimetric/Functional Parameters
|
Kocak, Zafer |
|
2271: Radiotherapy Combined with Bronchial Arterial Infusion of CDDP in the Treatment of Stage III Non-small Cell Lung Cancer - Its Impact on Disease Clearance and Long-term Survival
|
Karasawa, Katsuyuki |
|
2272: An Off-Line 4D Cone Beam CT Based Correction Protocol for Lung Tumor Motion
|
van Herk, Marcel |
|
2273: Outcome Variation in Non-Small Cell Lung Cancer Patients with Solitary Brain Metastasis
|
Hu, Chao-su |
|
2274: A Prospective Study of Radiation Induced Lung Injury: Measured Changes in Pulmonary Symptoms, Physiologic Function and CT Density
|
Lee, Justin |
|
2275: Synergistic Radiosensitization of Lung Cancer Cells using Parthenolide and Low Dose Combinations of Proteasome or Cycloxygenase Inhibitors
|
Warren, Graham |
|
2276: Induction Chemotherapy using Carboplatin(C), Irinotecan(I), and Paclitaxel(P) with Pegfilgrastim Followed by Concurrent Conformal Radiation Therapy (CRT) with Weekly Carboplatin/Paclitaxel and Daily Gefitinib (Iressa) Followed by Maintenance Gefitinib for Patients with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
|
Morris, David |
|
2277: Toxicity of Permanent I-125 Interstitial Planar Seed Brachytherapy for Close or Positive Margins for Thoracic Malignancies
|
Mutyala, Subhakar |
|
2278: Does the RTOG/EORTC Scoring Schema (RESS) Truly Reflect the Late Radiation Morbidity in Lung Cancer Patients?
|
Aslani, Maryam |
|
2279: Incidence of Treatment-Associated Toxicities in Medicare Non-Small Cell Lung Cancer (NSCLC) Patients
|
Baker, Gabrielle |
|
2280: A Comparison of Outcomes in Patients with Pathological Stage I-IIIB Non-Small Cell Lung Cancer Treated with Postoperative Two- or Three-Dimensional Conformal Radiotherapy
|
Zhu, Guang Ying |
|
2281: Prospective Study on Stereotactic Radiotherapy of Limited Stage Non-Small Cell Lung Cancer
|
Hoyer, Morten |
|
2282: Mechanisms of Radiosensitization by the Inhibitor of Histone Deacetylase NVP-LAQ824 in Human Lung Carcinoma Tumor Models
|
Geng, Ling |
|
2283: Promising Clinical Outcome of Stereotactic Body Radiosurgery in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer
|
Xia, Tingyi |
|
2284: 4D CT Planning Improves Tumor Control Probability (TCP) When Compared with Helical CT Scan in 3D Conformal Radiation Therapy (CRT) in Lung Cancer
|
Choi, Noah |
|
2285: A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer (RTOG 0214): How to Improve Accrual to an Important Prospective Randomized Study
|
Sun, Alex |
|
2286: Phase II Trial with Carboplatin/Gemcitabine (Cb/G) Induction Chemotherapy (CT) Followed by RadiotherapyConcomitantly with Paclitaxel/Gemcitabine (P/G) in Stage III Non-Small Cell Lung Cancer (NSCLC)
|
Duclos, Marie |
|
2287: CT Appearance of Radiation Injury of the Lung and Clinical Symptoms after Stereotactic Radiation Therapy (SRT) for Lung Cancers; Are Patients with Pulmonary Emphysema Good Candidates for SRT?
|
Kimura, Tomoki |
|
2288: Using FDG-PET to Delineate Gross Tumor and Internal Target Volumes
|
Fernando, Shaneli |
|
2289: Radiotherapy Following Extrapleural Pneumonectomy(EPP) for Mesothelioma: The Brigham and Women's HospitalExperience
|
Allen, Aaron |
|
2290: Serum Pro-Inflammatory Cytokines, Serum Manganese Superoxide Dismutase (MnSOD) and Dosimetric Metrics as Predictors for Acute Esophagitis Induced by Neoadjuvant Platinum-Based Chemotherapy and Thoracic Radiotherapy-A Prospective Study
|
Fan, Ming |
|
2291: Preliminary Results of the Prospective Randomized Phase III Trial of the Induction Chemotherapy and the ConcurrentChemoradiotherapy for the Locally Advanced Non-Small Cell Lung Cancer
|
Eun, Lee Jeong |
|
2292: Significantly Reduced Normal Tissue Dose with Proton Radiotherapy Compared with 3D-CRT or IMRT in Stage I or Stage III Non-Small Cell Lung Cancer
|
Chang, Joe |
|
2293: Thresholding Segmentation of FDG PET Lung Lesions for RT Planning Purposes
|
Soma, Laura |
|
2294: Serial Megavoltage CT Imaging For Non-Small Cell Lung Cancer: Observations on Tumor Regression During Treatment
|
Forbes, Alan |
|
2295: Predicting Effect of Plasma TGF-beta, IL-6, and ACE Levels for Radiation Pneumonitis in Patients Recieved Thoracic Irradiation
|
Wang, Luhua |
|
2296: Interobserver Variability in Non-Small Cell Lung Cancer Target Delineation Among Thoracic Radiation Oncologists
|
Borghero, Yerko |
|
2297: A Phase II Study of Induction Docetaxel/Cisplatin with rhG-CSF and Concurrent Pulsed Docetaxel Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)
|
Chen, Yuhchyau |
|
2298: Preliminary Report of Radiation Pneumonitis (RP) in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated withIntensity Modulated Radiotherapy (IMRT) and Concurrent Chemotherapy (ConChT)
|
Yom, Sue |
|
2299: Results of Institutional Differences in Treatment Planning for a Multi-institutional Trial of Stereotactic Radiotherapy for T1N0M0 Lung Cancer (JCOG0403)
|
Matsuo, Yukinori |
|
2300: Stereo-Tactic Body Radiotherapy Using Dual KV-XRAY On-Board Imaging System for Stage I Non-Small Cell Lung Cancer
|
Koto, Masashi |
|
2301: Intra- and Inter-Fraction Mediastinal Nodal Region Motion: Implications for Internal Target Volume Expansions
|
Thomas, J. |
|
2302: Stereotactic Fractionated Radiotherapy (SRT) for Intra-Thoracic Tumours
|
Van Parijs, Hilde |
|
2303: PET-CT for Patients (pts) Selection within a Multimodality Treatment Protocol (CTx + CTx/RTx +/- S) in Pts with LocallyAdvanced (LAD) Non-Small Cell Lung Cancer (NSCLC)(Inoperable Stage IIIA/Selected IIIB)
|
Stuschke, Martin |
|
2304: A Phase I Study of Gefitinib (Iressa) In Combination with Hypofractionated Thoracic Radiation Therapy (HRT) with Stereotactic Body Frame (SBF) Immobilization in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Preliminary Report on the First RT Dose Level
|
Werner-Wasik, Maria |
|
2305: Inter-Observer Variation in Target Delineation of Stage I Lung Cancer for Stereotactic Radiotherapy
|
Sakamoto, Masato |
|
2306: Metabolic PET Imaging for Stereotactic Body Radiation Therapy (SBRT) Planning and Therapy Response Assessment of Pulmonary Malignancies
|
Fuss, Martin |
|
2307: The Impact of Induction Chemotherapy on the Subsequent Response of Normal Lung and Tumor to Radiation
|
Mao, Jingfang |
|
2308: Gated Radiotherapy for Lung Tumors Using Infrared Detectors, Stereoscopic X-rays, and Implanted Markers
|
Willoughby, Twyla |
|
2309: Late Pulmonary Toxicity Associated with Chemotherapy and Radiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
|
Spencer, Sharon |
|
2310: Advantages of Respiration-Gated Radiotherapy for Stage III Lung Cancer
|
Underberg, Rene |
|
2311: Target Delineation in Radiation Therapy of Non-Small Cell Lung Cancer: A Correlation Study with Local Tumor Failure
|
Feng, F |
|
2312: Outcome of Patients Treated with Definitive versus Palliative Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer after Poor Radiographic Response to Induction Chemotherapy
|
Chen, Allen |
|
2313: Use of High Energy Photons Does Not Compromise Pathologic Response Rate in Treatment of Non-Small Cell Lung Cancer
|
DeYoung, Chad |
|
2314: A Phase I Study of Continuous Intravenous Infusion (CIV) Low-Dose Topotecan (T) Combined with Thoracic Radiotherapy (RT)
|
Chandra, Anurag |
|
2315: Suppression of Lung Cancer Cell Growth by Troglitazone (TGZ), a Ligand for Peroxisome Proliferator-Activated Receptor-Gamma
|
Chen, George |
|
2316: Stage IIIA Non-Small Cell Lung Cancers Treated with Neoadjuvant Concurrent Chemotherapy and High Dose Radiotherapy Followed by Resection
|
Shaikh, Arif |
|
